Cargando…
Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
Autores principales: | Zambelli, Alberto, Tondini, Carlo Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359055/ https://www.ncbi.nlm.nih.gov/pubmed/32661020 http://dx.doi.org/10.1136/esmoopen-2020-000836 |
Ejemplares similares
-
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group
por: Licata, Luca, et al.
Publicado: (2023) -
Multigene tests for breast cancer: the physician’s perspective
por: Cognetti, Francesco, et al.
Publicado: (2021) -
Estimation of COVID-19 outbreak size in Italy
por: Tuite, Ashleigh R, et al.
Publicado: (2020) -
Expected effects of COVID-19 outbreak on depression incidence in Italy
por: Mencacci, Claudio, et al.
Publicado: (2021) -
Mental health services in Italy during the COVID-19 outbreak
por: D'Agostino, Armando, et al.
Publicado: (2020)